Question
Number
448
Subject
Health
(RSV Vaccine eligibility)
(RSV Vaccine eligibility)
Asked by
Barry, Chiaka
Directed to
Minister for Health
Question asked on
14 May 2025
Answer due on
15 June 2025
Question asked
- Is the ACT policy in relation to eligibility for BeyfortusTM (nirsevimab), which protects infants not protected by antenatal Respiratory syncytial virus (RSV) vaccination, inconsistent with the policy of the Commonwealth; if so, why.
- Why did the ACT decide to limit access to infants born after 17 March 2025.
- Is it acceptable for infants under two years of age, born before 17 March 2025, not being able to access the protection from RSV that would be available to them if they lived in other States; if so, why.
- Is this policy being reviewed; if so, when does the Minister expect this inconsistency will be removed.